ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Gufic BioSciences Ltd reported revenue from operations of ₹260.8 Cr (+16.6% YoY) and net profit of ₹22.3 Cr (+70.2% YoY) for Q1 FY27.
Gufic Biosciences reported consolidated total income of ₹946.66 Crore for FY26. The board also recommended a final dividend of ₹0.10 per equity share.
Gufic BioSciences Ltd reported revenue from operations of ₹251.8 Cr (+22.8% YoY) and net profit of ₹21.9 Cr (+184.4% YoY) for Q4 FY26.
Gufic Biosciences reported audited FY26 results and recommended a 10% final dividend. The Board also approved a ₹5.75 Crore equity investment in Saraswat Co-operative Bank.